One-quarter of the world’s population has latent tuberculosis – with 10.4 million new cases and 1.7 million deaths reported in 2016 alone.
By Sarah Boseley, Health Editor
A new, shorter and safer drug regime for latent tuberculosis could help curb the global epidemic by increasing the numbers successfully treated and reducing the pool of infection, researchers believe.
Two ground breaking studies, one in adults and the other in children, have trialled a less toxic drug than the one in current use worldwide for latent TB and cut the treatment time from nine months to four.
To read the rest of this article from The Guardian click here
Want to see the rest of this article?
Would you like to see the rest of this article and all the other benefits that Issues Online can provide with?
- Useful related articles
- Video and multimedia references
- Statistical information and reference material
- Glossary of terms
- Key Facts and figures
- Related assignments
- Resource material and websites